Neuronetics

Neuronetics is a Pennsylvania-based medical device company that develops non-invasive therapies for the treatment of chronic psychiatric and neurological disorders.

Business Model:

Revenue: $62M

Employees: 51-200

Detailed Neuronetics Information

Geographic Data

Neuronetics headquarters map

Address: 3222 Phoenixville Pike

City: Malvern

State: PA

Zip: 19355

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$0

Raised Total:

$259M

Metrics

528,875Website Global Rank

88,045Website Monthly Traffic

Twitter Followers

Description

Neuronetics is a Pennsylvania-based medical device company that develops non-invasive therapies for the treatment of chronic psychiatric and neurological disorders.

Contact Phone:
+18776007555

Contact Email:

Neuronetics went public on 7/2/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/2/2018

IPO Valuation:
$284M

Ticker Symbol:
STIM

IPO Price:
$17/share

Amount Raised:
$108M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2003 Series A 4 $15M ONSET Ventures
KBL Healthcare Ventures
Investor Growth Capital Limited
InterWest Partners
ONSET Ventures
KBL Healthcare Ventures
Investor Growth Capital Limited
InterWest Partners
3/2005 Series B 5 $8.5M Three Arch Partners
ONSET Ventures
Investor Growth Capital Limited
InterWest Partners
Accuitive Medical Ventures
6/2017 Series G $0 Investor Growth Capital Limited
New Leaf Venture Partners
Accuitive Medical Ventures
Industry Ventures
ONSET Ventures
GE Ventures
KBL Healthcare Ventures
Pfizer Venture Investments
Ascension Ventures
InterWest Partners
Polaris Partners
Three Arch Partners
Investor Growth Capital Limited
New Leaf Venture Partners
Accuitive Medical Ventures
Industry Ventures
ONSET Ventures
GE Ventures
KBL Healthcare Ventures
Pfizer Venture Investments
Ascension Ventures
InterWest Partners
Polaris Partners
Three Arch Partners
5/2011 Series E 8 $30M Pfizer Venture Investments
Polaris Partners
Three Arch Partners
Quaker BioVentures
ONSET Ventures
New Leaf Venture Partners
Investor Growth Capital Limited
InterWest Partners
Pfizer Venture Investments
Polaris Partners
4/2015 Series F $0 GE Ventures
Partisan Management Group
Investor Growth Capital Limited
New Leaf Venture Partners
ONSET Ventures
Pfizer Venture Investments
Polaris Partners
Quaker BioVentures
Three Arch Partners
GE Ventures
Partisan Management Group
Investor Growth Capital Limited
New Leaf Venture Partners
ONSET Ventures
Pfizer Venture Investments
Polaris Partners
Quaker BioVentures
Three Arch Partners
1/2020 Debt Financing $50M
2/2021 Post-IPO Equity $80.6M
6/2022 Post-IPO Equity 1 - J Carlo Cannell
J Carlo Cannell
6/2018 IPO $93.5M
4/2020 Debt $6.4M Silicon Valley Bank
3/2020 Debt $50M Solar Capital Partners, LLC
12/2020 Post-IPO Debt 1 $15M Solar capital
Solar capital
10/2009 Series D $0 New Leaf Venture Partners
InterWest Partners
Investor Growth Capital Limited
KBL Healthcare Ventures
ONSET Ventures
Partisan Management Group
Quaker BioVentures
Three Arch Partners
New Leaf Venture Partners
InterWest Partners
Investor Growth Capital Limited
KBL Healthcare Ventures
ONSET Ventures
Partisan Management Group
Quaker BioVentures
Three Arch Partners
8/2006 Series C $0 InterWest Partners
Investor Growth Capital Limited
KBL Healthcare Ventures
ONSET Ventures
Quaker Partners
Three Arch Partners
InterWest Partners
Investor Growth Capital Limited
KBL Healthcare Ventures
ONSET Ventures
Quaker Partners
Three Arch Partners
6/2017 Series G 12 $15M Ascension Ventures
Accuitive Medical Ventures
GE Ventures
Interwest Partners
Industry Ventures
Investor Growth Capital
New Leaf Venture Partners
Onset Ventures
Pfizer
Polaris Venture Partners
Three Arch Partners
Investor Growth Capital Limited
New Leaf Venture Partners
Accuitive Medical Ventures
Industry Ventures
ONSET Ventures
GE Ventures
KBL Healthcare Ventures
Pfizer Venture Investments
Ascension Ventures
4/2015 Series F 9 $34.3M GE Ventures
GE Ventures
6/2022 Post-IPO Equity 1 - J Carlo Cannell
J Carlo Cannell
10/2009 Series D 8 $30M New Leaf Venture Partners
New Leaf Venture Partners
8/2006 Series C 6 $35M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research